Julphar new mebo legacy launches in UAE
Julphar has launched the new clinical trial of MEBO Scar in UAE, during two launch events that took place in Dubai and Abu Dhabi – respectively on October 21st and 22nd, 2016.
The two events gathered more than 300 healthcare professionals (HCPs) from UAE.
International speakers presented clinical cases to share their experience and successful outcomes of MEBO and MEBO Scar treatment, and shared with the attending audience the latest updates on the ongoing new clinical trial of MEBO Scar in collaboration with Manchester University and Al Mafraq Hospital.
“We are now entering a new era in the life stage of MEBO and MEBO Scar to develop and modernize Julphar brand,” said Dr Hosam Badr, Marketing Director at Julphar. “Whilst keeping same quality, safety and efficiency, MEBO and MEBO Scar are presented today with updated data and new identity that will reflect our long-term commitment to our patient’s quality of life.”
MEBO is recommended for the healing of both chronic and acute wounds.
MEBO Scar is recommended to reduce and prevent formation of scars and to improve skin elasticity and vitality.
See the photos of the event on our Flickr page!
.jpg)
